Clinical Trial Update: Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease [Phase 1]

View source ↗

Summary

Biogen's Phase 1 single ascending dose trial of BIIB037 in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BIIB037

Snippet

Sponsor: Biogen | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED